PSS10 COST-EFFECTIVENESS OF ANTIVEGF THERAPIES FOR WET AGE-RELATED MACULAR DEGENERATION-AMD IN BRAZIL- THE PRIVATE PAYER PERSPECTIVE
May 1, 2008, 00:00
10.1016/S1098-3015(10)70905-0
https://www.valueinhealthjournal.com/article/S1098-3015(10)70905-0/fulltext
Title :
PSS10 COST-EFFECTIVENESS OF ANTIVEGF THERAPIES FOR WET AGE-RELATED MACULAR DEGENERATION-AMD IN BRAZIL- THE PRIVATE PAYER PERSPECTIVE
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)70905-0&doi=10.1016/S1098-3015(10)70905-0
First page :
Section Title :
Open access? :
No
Section Order :
661